Clene Newsroom

Maxim Group Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsDec 11 15:31 ET

H.C. Wainwright Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsDec 10 09:32 ET

Clene Price Target Maintained With a $23.00/Share by D. Boral Capital

Dow JonesDec 10 09:27 ET

Clene Is Maintained at Buy by D. Boral Capital

Dow JonesDec 10 09:27 ET

Clene Analyst Ratings

BenzingaDec 10 09:17 ET

Benchmark Maintains Buy on Clene, Lowers Price Target to $84

BenzingaNov 22 09:57 ET

Clene Price Target Maintained With a $23.00/Share by D. Boral Capital

Dow JonesNov 13 17:37 ET

Clene Is Maintained at Buy by D. Boral Capital

Dow JonesNov 13 17:37 ET

Clene Analyst Ratings

BenzingaNov 13 17:27 ET

H.C. Wainwright Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsNov 13 10:33 ET

Clene's Strategic and Financial Strengths Justify Buy Rating Amid Promising ALS Therapeutic Developments

TipRanksNov 13 09:47 ET

Clene Price Target Maintained With a $23.00/Share by EF Hutton

Dow JonesOct 24 08:15 ET

Clene Is Maintained at Buy by EF Hutton

Dow JonesOct 24 08:15 ET

Clene Analyst Ratings

BenzingaOct 24 05:42 ET

H.C. Wainwright Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsOct 23 10:32 ET

Strategic Advancements and Robust Trial Design Drive Buy Rating for Clene

TipRanksOct 23 10:18 ET

Benchmark Co. Sticks to Their Buy Rating for Clene (CLNN)

TipRanksOct 11 07:08 ET

Clene Is Maintained at Buy by EF Hutton

Dow JonesOct 2 11:05 ET

Clene Price Target Maintained With a $23.00/Share by EF Hutton

Dow JonesOct 2 11:05 ET

Clene Analyst Ratings

BenzingaOct 2 10:55 ET